BCL2 and breast carcinoma: Moreover, we identified miR-134-3p, whose expression was described to be down-regulated in breast cancer [29], while overexpression of this miRNA was reported to reduce breast cancer cell proliferation through targeting of apoptosis-inhibiting genes like BCL2 [30].